Ajanta Pharma fenofibrate capsules recalled for CGMP deviations
Ajanta Pharma USA Inc. is recalling one lot of fenofibrate 200 mg capsules due to manufacturing quality deviations discovered during inspection. The affected lot (PA02216, expiring 12/2029) was distributed nationwide.
From the FDA notice · Read the official notice ↗ · All Ajanta Pharma recalls
What to do
- Check your medication bottle for lot number PA02216 and expiration date 12/2029.
- Contact your pharmacy or doctor if you have this lot; do not stop taking fenofibrate without medical guidance.
- Return unused medication to your pharmacy for proper disposal.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 3648 bottles
- Illnesses reported
- None reported
- Manufactured in
- 400 Crossing Blvd Ste 102, N/A, Bridgewater, NJ, United States
- Classification
- Class II
- Recall number
- D-0611-2026
In the FDA's words
- Description
- Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04. CGMP Deviations Lot # PA02216; Exp. 12/2029 Distribution: U.S. Nationwide Affected quantity: 3648 bottles
- Hazard
- CGMP Deviations
More from Ajanta Pharma
See all- Ajanta Pharma ranolazine tablets recalled for failed dissolution
ModerateFDAOct 7, 2026
- Ajanta Pharma fluphenazine tablets recalled for high impurity level
ModerateFDASep 16, 2026